Companies / Tenaya Therapeutics, Inc.

Tenaya Therapeutics, Inc.

Nasdaq: TNYACIK 1858848SOUTH SAN FRANCISCO, CA

Financials

Revenue
Net income$-90.60M
Total debt
Cash$78.08M
Diluted EPS$-0.59
Shares outstanding224.2M

Ownership

224.2M shares outstanding · as of Jul 30, 2026
0.35%Insiders
Ownership
Insiders0.35%781,774
Institutions32.50%72,883,009
Public float67.15%150,565,229

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 12

View all →
Insider% of sharesShares
Ali FarazCEOChief Executive Officer · Director
0.20%443,404
Tingley WhittemoreChief Medical Officer
0.10%218,618
Higa TomohiroSVP, Finance
0.05%119,752
0.00%0
Kutzkey Tim10% owner

Institutional holders 99

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 11, 2026The Column Group III GP, LP
10% owner
SellCommon Stock$1.46M-2.2M
-44.79%
2,651,817
1.18% of shares
medium
Feb 11, 2026The Column Group III GP, LP
10% owner
SellCommon Stock$1.30M-1.9M
-44.79%
2,348,183
1.05% of shares
medium
Feb 25, 2026The Column Group III GP, LP
10% owner
SellCommon Stock$1.05M-1.9M
-100.00%
0
0.00% of shares
medium
Feb 25, 2026The Column Group III GP, LP
10% owner
SellCommon Stock$927.6K-1.6M
-100.00%
0
0.00% of shares
medium
Feb 24, 2026The Column Group III GP, LP
10% owner
SellCommon Stock$214.9K-349K
-15.79%
1,862,545
0.83% of shares
medium
Feb 24, 2026The Column Group III GP, LP
10% owner
SellCommon Stock$190.3K-309K
-15.79%
1,649,281
0.74% of shares
medium
Feb 20, 2026The Column Group III GP, LP
10% owner
SellCommon Stock$170.8K-278K
-10.47%
2,374,048
1.06% of shares
medium
Feb 20, 2026The Column Group III GP, LP
10% owner
SellCommon Stock$151.2K-246K
-10.47%
2,102,218
0.94% of shares
medium

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
TNYACommon StockEquity87990A106BBG00FPMK2S3